Breast Cancer News & Features

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

Education Reduces Distress During Breast Cancer Treatment

January 31, 2012

Physical, emotional, and social adjustment occurs over time with or without interventions
 

Parabens found in breast tumor tissue of nonusers of underarm products

January 30, 2012

Chemicals known as parabens, which may have a role in breast cancer and are commonly used as preservatives in cosmetics, food products, and pharmaceuticals, have now been found in measurable levels in the breast tissue of women who do not use underarm products.
 

Not Enough Americans Being Screened for Cancer

January 26, 2012

Rates of cancer screening in the United States are short of Healthy People 2020 targets for breast, cervical, and colorectal cancer screening
 

Radiation Benefits Mixed After Breast-Preserving Surgery

January 26, 2012

Radiation therapy slightly improves survival, but may increase likelihood of eventual mastectomy.
 

Bevacizumab Efficacious for HER2-Negative Breast Cancer

January 25, 2012

Two studies show improved pathologic complete response with addition of bevacizumab.
 

More Adverse QOL Issues in Young Breast Cancer Patients

January 25, 2012

Younger women with breast cancer experience increased psychological distress, fertility-related concerns, and decreased physical activity, a new review found.
 

Information gap may skew mastectomy decisions

January 23, 2012

Women with early-stage breast cancer often lacked knowledge about their disease and were not asked their preference regarding surgery, according to recent survey findings.
 

Many parents tell kids about breast cancer gene test results

January 20, 2012

Parents are more likely than not to tell their sons and daughters younger than 25 years whether or not the parent carries inheritable mutations in BRCA1 or BRCA2 genes.
 

Meditation technique brings peace of mind to breast cancer survivors

Delicia Honen Yard January 16, 2012

Mindfulness-based stress reduction (MBSR) showed a trend toward improving psychological outcomes by reducing mood disturbance in women who had survived early-stage breast cancer.
 

Breast Cancer Clinical Trials

Clinical Trial: MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer

Clinical Trial: Pre-Surgery Positron Emission Mammography in Patients With Newly Diagnosed Breast Cancer

Clinical Trial: Circadian Disturbances After Breast Cancer Surgery (CIRCA)

Clinical Trial: Genomic Testing for Primary Breast Cancer

Clinical Trial: Breast Cancer Prevention Education

Free CE from mycme.com

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)TM
This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.
 

Cancer care is expensive.
CancerCare can help.


Connect Booklets
FEBRUARY 3 - 4
• 2012 Highlights of ASH in North America
New York, New York
• 2012 Highlights of ASH in North America
San Francisco, California
MARCH 3 - 4
• 2012 Highlights of ASH in Asia
Singapore, Singapore
MAY 3 - 6
• 37th Annual ONS Congress
New Orleans, Louisiana
 Subscribe to the RSS for this page  [view all our RSS feeds here]

Web Exclusives

Psychosocial approach useful in managing cancer pain

February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.
 

Experimental agent slows progression of colorectal cancer

February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.
 

In HER2 breast cancer, lapatinib works better with trastuzumab than without

February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.
 

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions